Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Outlook, In‑Depth Analysis & Forecast to 2032

Table of Contents

1 Study Coverage
    1.1 Introduction to 3-(1-Piperazinyl)-1,2-benzisothiazole: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Type, 2021 vs 2025 vs 2032
        1.2.2 Purity 99%
        1.2.3 Purity 98.5%
        1.2.4 Purity 98%
        1.2.5 Others
    1.3 Market Segmentation by Application
        1.3.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Application, 2021 vs 2025 vs 2032
        1.3.2 Organic Synthesis Intermediates
        1.3.3 Pharmaceutical Intermediates
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Estimates and Forecasts (2021-2032)
    2.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Region
        2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
        2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
    2.3 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Estimates and Forecasts (2021-2032)
    2.4 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Region
        2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
        2.4.2 Global Sales Market Share by Region (2021-2032)
        2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
    2.5 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production Capacity and Utilization (2021 vs 2025 vs 2032)
    2.6 Production Comparison by Region: 2021 vs 2025 vs 2032

3 Competitive Landscape
    3.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Manufacturers
        3.1.1 Global Sales Volume by Manufacturers (2021-2026)
        3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
    3.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturer Revenue Rankings and Tiers
        3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
        3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
        3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
    3.3 Manufacturer Profitability Profiles and Pricing Strategies
        3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
        3.3.2 Manufacturer-Level Price Trends (2021-2026)
    3.4 Key Manufacturers Manufacturing Base and Headquarters
    3.5 Key Manufacturers Market Share by Product Type
        3.5.1 Purity 99%: Market Share by Key Manufacturers
        3.5.2 Purity 98.5%: Market Share by Key Manufacturers
        3.5.3 Purity 98%: Market Share by Key Manufacturers
        3.5.4 Others: Market Share by Key Manufacturers
    3.6 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Concentration and Dynamics
        3.6.1 Global Market Concentration
        3.6.2 Market Entry and Exit Analysis
        3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
    4.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Performance by Type
        4.1.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (2021-2032)
        4.1.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Type (2021-2032)
        4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
    4.2 Product Technology Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Downstream Applications and Customers
    5.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application
        5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
        5.1.2 Global Sales Market Share by Application (2021-2032)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Application
        5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
        5.2.2 Revenue-Based Market Share by Application (2021-2032)
    5.3 Global Pricing Dynamics by Application (2021-2032)
    5.4 Downstream Customer Analysis
        5.4.1 Top Customers by Region
        5.4.2 Top Customers by Application

6 Global Production Analysis
    6.1 Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production Capacity and Utilization Rates (2021–2032)
    6.2 Regional Production Dynamics and Outlook
        6.2.1 Historic Production by Region (2021-2026)
        6.2.2 Forecasted Production by Region (2027-2032)
        6.2.3 Production Market Share by Region (2021-2032)
        6.2.4 Regulatory and Trade Policy Impact on Production
        6.2.5 Production Capacity Enablers and Constraints
    6.3 Key Regional Production Hubs
        6.3.1 North America
        6.3.2 Europe
        6.3.3 China
        6.3.4 Japan
        6.3.5 India

7 North America
    7.1 North America Sales Volume and Revenue (2021-2032)
    7.2 North America Key Manufacturers Sales Revenue in 2025
    7.3 North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales and Revenue by Application (2021-2032)
    7.4 North America Growth Accelerators and Market Barriers
    7.5 North America 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Country
        7.5.1 North America Revenue by Country
        7.5.2 North America Sales Trends by Country
        7.5.3 US
        7.5.4 Canada
        7.5.5 Mexico

8 Europe
    8.1 Europe Sales Volume and Revenue (2021-2032)
    8.2 Europe Key Manufacturers Sales Revenue in 2025
    8.3 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales and Revenue by Application (2021-2032)
    8.4 Europe Growth Accelerators and Market Barriers
    8.5 Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Country
        8.5.1 Europe Revenue by Country
        8.5.2 Europe Sales Trends by Country
        8.5.3 Germany
        8.5.4 France
        8.5.5 U.K.
        8.5.6 Italy
        8.5.7 Russia

9 Asia-Pacific
    9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
    9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
    9.3 Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales and Revenue by Application (2021-2032)
    9.4 Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Region
        9.4.1 Asia-Pacific Revenue by Region
        9.4.2 Asia-Pacific Sales Trends by Region
    9.5 Asia-Pacific Growth Accelerators and Market Barriers
    9.6 Southeast Asia
        9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
        9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
    9.7 China
    9.8 Japan
    9.9 South Korea
    9.10 China Taiwan
    9.11 India

10 Central and South America
    10.1 Central and South America Sales Volume and Revenue (2021-2032)
    10.2 Central and South America Key Manufacturers Sales Revenue in 2025
    10.3 Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales and Revenue by Application (2021-2032)
    10.4 Central and South America Investment Opportunities and Key Challenges
    10.5 Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Country
        10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
        10.5.2 Brazil
        10.5.3 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
    11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
    11.3 Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales and Revenue by Application (2021-2032)
    11.4 Middle East and Africa Investment Opportunities and Key Challenges
    11.5 Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size by Country
        11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
        11.5.2 GCC Countries
        11.5.3 Turkey
        11.5.4 Egypt
        11.5.5 South Africa

12 Corporate Profile
    12.1 Ontario Chemicals, Inc
        12.1.1 Ontario Chemicals, Inc Corporation Information
        12.1.2 Ontario Chemicals, Inc Business Overview
        12.1.3 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.1.4 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.1.5 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Product in 2025
        12.1.6 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application in 2025
        12.1.7 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Geographic Area in 2025
        12.1.8 Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
        12.1.9 Ontario Chemicals, Inc Recent Developments
    12.2 CNH Technologies, Inc.
        12.2.1 CNH Technologies, Inc. Corporation Information
        12.2.2 CNH Technologies, Inc. Business Overview
        12.2.3 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.2.4 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.2.5 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Product in 2025
        12.2.6 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application in 2025
        12.2.7 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Geographic Area in 2025
        12.2.8 CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
        12.2.9 CNH Technologies, Inc. Recent Developments
    12.3 VGS Synthesis
        12.3.1 VGS Synthesis Corporation Information
        12.3.2 VGS Synthesis Business Overview
        12.3.3 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.3.4 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.3.5 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Product in 2025
        12.3.6 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application in 2025
        12.3.7 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Geographic Area in 2025
        12.3.8 VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
        12.3.9 VGS Synthesis Recent Developments
    12.4 Vihita Chem
        12.4.1 Vihita Chem Corporation Information
        12.4.2 Vihita Chem Business Overview
        12.4.3 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.4.4 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.4.5 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Product in 2025
        12.4.6 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application in 2025
        12.4.7 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Geographic Area in 2025
        12.4.8 Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
        12.4.9 Vihita Chem Recent Developments
    12.5 Integrin Life Sciences
        12.5.1 Integrin Life Sciences Corporation Information
        12.5.2 Integrin Life Sciences Business Overview
        12.5.3 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.5.4 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.5.5 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Product in 2025
        12.5.6 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application in 2025
        12.5.7 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Geographic Area in 2025
        12.5.8 Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
        12.5.9 Integrin Life Sciences Recent Developments
    12.6 Sintilla Medcoms
        12.6.1 Sintilla Medcoms Corporation Information
        12.6.2 Sintilla Medcoms Business Overview
        12.6.3 Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.6.4 Sintilla Medcoms 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.6.5 Sintilla Medcoms Recent Developments
    12.7 PSN Medicare
        12.7.1 PSN Medicare Corporation Information
        12.7.2 PSN Medicare Business Overview
        12.7.3 PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.7.4 PSN Medicare 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.7.5 PSN Medicare Recent Developments
    12.8 Lakshmi Farmachem
        12.8.1 Lakshmi Farmachem Corporation Information
        12.8.2 Lakshmi Farmachem Business Overview
        12.8.3 Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.8.4 Lakshmi Farmachem 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.8.5 Lakshmi Farmachem Recent Developments
    12.9 Jinan Jianfeng Chemical
        12.9.1 Jinan Jianfeng Chemical Corporation Information
        12.9.2 Jinan Jianfeng Chemical Business Overview
        12.9.3 Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.9.4 Jinan Jianfeng Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.9.5 Jinan Jianfeng Chemical Recent Developments
    12.10 Xi'an Yutebang Pharmaceutical Technology
        12.10.1 Xi'an Yutebang Pharmaceutical Technology Corporation Information
        12.10.2 Xi'an Yutebang Pharmaceutical Technology Business Overview
        12.10.3 Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.10.4 Xi'an Yutebang Pharmaceutical Technology 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.10.5 Xi'an Yutebang Pharmaceutical Technology Recent Developments
    12.11 Shanghai Sunwise Chemical
        12.11.1 Shanghai Sunwise Chemical Corporation Information
        12.11.2 Shanghai Sunwise Chemical Business Overview
        12.11.3 Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.11.4 Shanghai Sunwise Chemical 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.11.5 Shanghai Sunwise Chemical Recent Developments
    12.12 Jinan Aery Pharmaceutical
        12.12.1 Jinan Aery Pharmaceutical Corporation Information
        12.12.2 Jinan Aery Pharmaceutical Business Overview
        12.12.3 Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Product Models, Descriptions and Specifications
        12.12.4 Jinan Aery Pharmaceutical 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
        12.12.5 Jinan Aery Pharmaceutical Recent Developments

13 Value Chain and Supply-Chain Analysis
    13.1 3-(1-Piperazinyl)-1,2-benzisothiazole Industry Chain
    13.2 3-(1-Piperazinyl)-1,2-benzisothiazole Upstream Materials Analysis
        13.2.1 Raw Materials
        13.2.2 Key Suppliers Market Share & Risk Assessment
    13.3 3-(1-Piperazinyl)-1,2-benzisothiazole Integrated Production Analysis
        13.3.1 Manufacturing Footprint Analysis
        13.3.2 Production Technology Overview
        13.3.3 Regional Cost Drivers
    13.4 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Channels and Distribution Networks
        13.4.1 Sales Channels
        13.4.2 Distributors

14 3-(1-Piperazinyl)-1,2-benzisothiazole Market Dynamics
    14.1 Industry Trends and Evolution
    14.2 Market Growth Drivers and Emerging Opportunities
    14.3 Market Challenges, Risks, and Restraints
    14.4 Impact of U.S. Tariffs

15 Key Findings in the Global 3-(1-Piperazinyl)-1,2-benzisothiazole Study

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
            16.1.1.1 Research Programs/Design
            16.1.1.2 Market Size Estimation
            16.1.1.3 Market Breakdown and Data Triangulation
        16.1.2 Data Source
            16.1.2.1 Secondary Sources
            16.1.2.2 Primary Sources
    16.2 Author Details

Table of Figures

List of Tables
 Table 1. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Table 2. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Table 3. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 4. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 5. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 6. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 7. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Manufacturers (Tons), 2021-2026
 Table 8. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Share by Manufacturers (2021-2026)
 Table 9. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Manufacturers (US$ Million), 2021-2026
 Table 10. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue-Based Market Share by Manufacturers (2021-2026)
 Table 11. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
 Table 12. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue, 2025
 Table 13. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Gross Margin (%) by Manufacturer (2021 vs 2025)
 Table 14. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Average Selling Price (ASP) by Manufacturers (US$/Ton), 2021-2026
 Table 15. Key Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturing Base and Headquarters
 Table 16. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Concentration Ratio (CR5)
 Table 17. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
 Table 18. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 19. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (Tons), 2021-2026
 Table 20. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume by Type (Tons), 2027-2032
 Table 21. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Type (US$ Million), 2021-2026
 Table 22. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Type (US$ Million), 2027-2032
 Table 23. Technical Specifications by Key Product Type
 Table 24. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application (Tons), 2021-2026
 Table 25. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales by Application (Tons), 2027-2032
 Table 26. 3-(1-Piperazinyl)-1,2-benzisothiazole High-Growth Sectors Demand CAGR (2026-2032)
 Table 27. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Application (US$ Million), 2021-2026
 Table 28. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue by Application (US$ Million), 2027-2032
 Table 29. Top Customers by Region
 Table 30. Top Customers by Application
 Table 31. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production by Region (Tons), 2021-2026
 Table 32. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production by Region (Tons), 2027-2032
 Table 33. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Growth Accelerators and Market Barriers
 Table 34. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 35. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons) by Country (2021 vs 2025 vs 2032)
 Table 36. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Growth Accelerators and Market Barriers
 Table 37. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons) by Country (2021 vs 2025 vs 2032)
 Table 39. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 40. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons) by Country (2021 vs 2025 vs 2032)
 Table 41. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Growth Accelerators and Market Barriers
 Table 42. Southeast Asia 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Investment Opportunities and Key Challenges
 Table 44. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 45. Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Investment Opportunities and Key Challenges
 Table 46. Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
 Table 47. Ontario Chemicals, Inc Corporation Information
 Table 48. Ontario Chemicals, Inc Description and Major Businesses
 Table 49. Ontario Chemicals, Inc Product Models, Descriptions and Specifications
 Table 50. Ontario Chemicals, Inc Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 51. Ontario Chemicals, Inc Sales Value Proportion by Product in 2025
 Table 52. Ontario Chemicals, Inc Sales Value Proportion by Application in 2025
 Table 53. Ontario Chemicals, Inc Sales Value Proportion by Geographic Area in 2025
 Table 54. Ontario Chemicals, Inc 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
 Table 55. Ontario Chemicals, Inc Recent Developments
 Table 56. CNH Technologies, Inc. Corporation Information
 Table 57. CNH Technologies, Inc. Description and Major Businesses
 Table 58. CNH Technologies, Inc. Product Models, Descriptions and Specifications
 Table 59. CNH Technologies, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 60. CNH Technologies, Inc. Sales Value Proportion by Product in 2025
 Table 61. CNH Technologies, Inc. Sales Value Proportion by Application in 2025
 Table 62. CNH Technologies, Inc. Sales Value Proportion by Geographic Area in 2025
 Table 63. CNH Technologies, Inc. 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
 Table 64. CNH Technologies, Inc. Recent Developments
 Table 65. VGS Synthesis Corporation Information
 Table 66. VGS Synthesis Description and Major Businesses
 Table 67. VGS Synthesis Product Models, Descriptions and Specifications
 Table 68. VGS Synthesis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 69. VGS Synthesis Sales Value Proportion by Product in 2025
 Table 70. VGS Synthesis Sales Value Proportion by Application in 2025
 Table 71. VGS Synthesis Sales Value Proportion by Geographic Area in 2025
 Table 72. VGS Synthesis 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
 Table 73. VGS Synthesis Recent Developments
 Table 74. Vihita Chem Corporation Information
 Table 75. Vihita Chem Description and Major Businesses
 Table 76. Vihita Chem Product Models, Descriptions and Specifications
 Table 77. Vihita Chem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 78. Vihita Chem Sales Value Proportion by Product in 2025
 Table 79. Vihita Chem Sales Value Proportion by Application in 2025
 Table 80. Vihita Chem Sales Value Proportion by Geographic Area in 2025
 Table 81. Vihita Chem 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
 Table 82. Vihita Chem Recent Developments
 Table 83. Integrin Life Sciences Corporation Information
 Table 84. Integrin Life Sciences Description and Major Businesses
 Table 85. Integrin Life Sciences Product Models, Descriptions and Specifications
 Table 86. Integrin Life Sciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 87. Integrin Life Sciences Sales Value Proportion by Product in 2025
 Table 88. Integrin Life Sciences Sales Value Proportion by Application in 2025
 Table 89. Integrin Life Sciences Sales Value Proportion by Geographic Area in 2025
 Table 90. Integrin Life Sciences 3-(1-Piperazinyl)-1,2-benzisothiazole SWOT Analysis
 Table 91. Integrin Life Sciences Recent Developments
 Table 92. Sintilla Medcoms Corporation Information
 Table 93. Sintilla Medcoms Description and Major Businesses
 Table 94. Sintilla Medcoms Product Models, Descriptions and Specifications
 Table 95. Sintilla Medcoms Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 96. Sintilla Medcoms Recent Developments
 Table 97. PSN Medicare Corporation Information
 Table 98. PSN Medicare Description and Major Businesses
 Table 99. PSN Medicare Product Models, Descriptions and Specifications
 Table 100. PSN Medicare Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 101. PSN Medicare Recent Developments
 Table 102. Lakshmi Farmachem Corporation Information
 Table 103. Lakshmi Farmachem Description and Major Businesses
 Table 104. Lakshmi Farmachem Product Models, Descriptions and Specifications
 Table 105. Lakshmi Farmachem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 106. Lakshmi Farmachem Recent Developments
 Table 107. Jinan Jianfeng Chemical Corporation Information
 Table 108. Jinan Jianfeng Chemical Description and Major Businesses
 Table 109. Jinan Jianfeng Chemical Product Models, Descriptions and Specifications
 Table 110. Jinan Jianfeng Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 111. Jinan Jianfeng Chemical Recent Developments
 Table 112. Xi'an Yutebang Pharmaceutical Technology Corporation Information
 Table 113. Xi'an Yutebang Pharmaceutical Technology Description and Major Businesses
 Table 114. Xi'an Yutebang Pharmaceutical Technology Product Models, Descriptions and Specifications
 Table 115. Xi'an Yutebang Pharmaceutical Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 116. Xi'an Yutebang Pharmaceutical Technology Recent Developments
 Table 117. Shanghai Sunwise Chemical Corporation Information
 Table 118. Shanghai Sunwise Chemical Description and Major Businesses
 Table 119. Shanghai Sunwise Chemical Product Models, Descriptions and Specifications
 Table 120. Shanghai Sunwise Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 121. Shanghai Sunwise Chemical Recent Developments
 Table 122. Jinan Aery Pharmaceutical Corporation Information
 Table 123. Jinan Aery Pharmaceutical Description and Major Businesses
 Table 124. Jinan Aery Pharmaceutical Product Models, Descriptions and Specifications
 Table 125. Jinan Aery Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
 Table 126. Jinan Aery Pharmaceutical Recent Developments
 Table 127. Key Raw Materials Distribution
 Table 128. Raw Materials Key Suppliers
 Table 129. Critical Raw Material Supplier Concentration (2025) & Risk Index
 Table 130. Milestones in Production Technology Evolution
 Table 131. Distributors List
 Table 132. Market Trends and Market Evolution
 Table 133. Market Drivers and Opportunities
 Table 134. Market Challenges, Risks, and Restraints
 Table 135. Research Programs/Design for This Report
 Table 136. Key Data Information from Secondary Sources
 Table 137. Key Data Information from Primary Sources


List of Figures
 Figure 1. 3-(1-Piperazinyl)-1,2-benzisothiazole Product Picture
 Figure 2. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Purity 99% Product Picture
 Figure 4. Purity 98.5% Product Picture
 Figure 5. Purity 98% Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 8. Organic Synthesis Intermediates
 Figure 9. Pharmaceutical Intermediates
 Figure 10. Others
 Figure 11. 3-(1-Piperazinyl)-1,2-benzisothiazole Report Years Considered
 Figure 12. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 14. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 15. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue-Based Market Share by Region (2021-2032)
 Figure 16. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (Tons), 2021-2032
 Figure 17. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 18. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share by Region (2021-2032)
 Figure 19. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Production and Utilization (Tons), 2021 vs 2025 vs 2032
 Figure 20. Top 5 and Top 10 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume Market Share in 2025
 Figure 21. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue-Based Market Share Ranking (2025)
 Figure 22. Tier Distribution by Revenue Contribution (2021 vs 2025)
 Figure 23. Purity 99% Revenue-Based Market Share by Manufacturer in 2025
 Figure 24. Purity 98.5% Revenue-Based Market Share by Manufacturer in 2025
 Figure 25. Purity 98% Revenue-Based Market Share by Manufacturer in 2025
 Figure 26. Others Revenue-Based Market Share by Manufacturer in 2025
 Figure 27. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume-Based Market Share by Type (2021-2032)
 Figure 28. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue-Based Market Share by Type (2021-2032)
 Figure 29. Global 3-(1-Piperazinyl)-1,2-benzisothiazole ASP by Type (US$/Ton), 2021-2032
 Figure 30. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Share by Application (2021-2032)
 Figure 31. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue-Based Market Share by Application (2021-2032)
 Figure 32. Global 3-(1-Piperazinyl)-1,2-benzisothiazole ASP by Application (US$/Ton), 2021-2032
 Figure 33. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Capacity, Production and Utilization (Tons), 2021-2032
 Figure 34. Global 3-(1-Piperazinyl)-1,2-benzisothiazole Production Market Share by Region (2021-2032)
 Figure 35. Production Capacity Enablers & Constraints
 Figure 36. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate in North America (Tons), 2021-2032
 Figure 37. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate in Europe (Tons), 2021-2032
 Figure 38. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate in China (Tons), 2021-2032
 Figure 39. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate in Japan (Tons), 2021-2032
 Figure 40. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Growth Rate in India (Tons), 2021-2032
 Figure 41. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales YoY (Tons), 2021-2032
 Figure 42. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue YoY (US$ Million), 2021-2032
 Figure 43. North America Top 5 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) in 2025
 Figure 44. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons) by Application (2021-2032)
 Figure 45. North America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 46. US 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 47. Canada 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 48. Mexico 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 49. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales YoY (Tons), 2021-2032
 Figure 50. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue YoY (US$ Million), 2021-2032
 Figure 51. Europe Top 5 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) in 2025
 Figure 52. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons) by Application (2021-2032)
 Figure 53. Europe 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 54. Germany 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 55. France 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 56. U.K. 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 57. Italy 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 58. Russia 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 59. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales YoY (Tons), 2021-2032
 Figure 60. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue YoY (US$ Million), 2021-2032
 Figure 61. Asia-Pacific Top 8 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) in 2025
 Figure 62. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons) by Application (2021-2032)
 Figure 63. Asia-Pacific 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 64. Indonesia 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 65. Japan 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 66. South Korea 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 67. China Taiwan 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 68. India 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 69. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales YoY (Tons), 2021-2032
 Figure 70. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue YoY (US$ Million), 2021-2032
 Figure 71. Central and South America Top 5 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) in 2025
 Figure 72. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons) by Application (2021-2032)
 Figure 73. Central and South America 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 74. Brazil 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 75. Argentina 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 76. Middle East, and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales YoY (Tons), 2021-2032
 Figure 77. Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue YoY (US$ Million), 2021-2032
 Figure 78. Middle East and Africa Top 5 Manufacturers 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) in 2025
 Figure 79. Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Volume (Tons) by Application (2021-2032)
 Figure 80. Middle East and Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Revenue (US$ Million) by Application (2021-2032)
 Figure 81. GCC Countries 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 82. Turkey 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 83. Egypt 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 84. South Africa 3-(1-Piperazinyl)-1,2-benzisothiazole Revenue (US$ Million), 2021-2032
 Figure 85. 3-(1-Piperazinyl)-1,2-benzisothiazole Industry Chain Mapping
 Figure 86. Regional 3-(1-Piperazinyl)-1,2-benzisothiazole Manufacturing Base Distribution (%)
 Figure 87. 3-(1-Piperazinyl)-1,2-benzisothiazole Production Process
 Figure 88. Regional 3-(1-Piperazinyl)-1,2-benzisothiazole Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed

Related Reports

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Insights, Forecast to 2030

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.

  

  Published: 2024-06-11

  

  Pages: 170

  USD 4900.00

  (Single User License)

• 

  Global and United States 3-(1-Piperazinyl)-1,2-benzisothiazole Market Report & Forecast 2024-2030

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

  

  Published: 2024-06-11

  

  Pages: 124

  USD 4350.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Research Report 2024

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

  

  Published: 2024-06-11

  

  Pages: 104

  USD 2900.00

  (Single User License)

• 

  3-(1-Piperazinyl)-1,2-benzisothiazole - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

  

  Published: 2025-03-10

  

  Pages: 126

  USD 3950.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Research Report 2025

  The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

  

  Published: 2025-03-10

  

  Pages: 96

  USD 2900.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

  

  Published: 2025-03-10

  

  Pages: 99

  USD 4250.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Outlook, In‑Depth Analysis & Forecast to 2031

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

  

  Published: 2025-08-05

  

  Pages: 168

  USD 4900.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Market Research Report 2026

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

  

  Published: 2026-01-14

  

  Pages: 136

  USD 2900.00

  (Single User License)

• 

  3-(1-Piperazinyl)-1,2-benzisothiazole- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  The global market for 3-(1-Piperazinyl)-1,2-benzisothiazole was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

  

  Published: 2026-01-19

  

  Pages: 127

  USD 3950.00

  (Single User License)

• 

  Global 3-(1-Piperazinyl)-1,2-benzisothiazole Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

  The global 3-(1-Piperazinyl)-1,2-benzisothiazole market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.

  

  Published: 2026-03-26

  

  Pages: 93

  USD 4250.00

  (Single User License)